Modeling promising nonmyeloablative conditioning regimens in nonhuman primates.

Area of Science:

• Hematology
• Gene Therapy
• Transplantation Immunology

Background:

• Minimal or no conditioning is preferred for gene therapy in nonmalignant diseases.
• Reduced intensity conditioning (RIC) has shown limited long-term engraftment in nonhematologic malignancies without a selective advantage for donor cells.
• Inadequate myelosuppression is suspected as a cause for poor engraftment in previous studies.

Purpose of the Study:

• To evaluate novel RIC regimens in nonhuman primates, a relevant large animal model.
• To assess the efficacy of selective myelosuppression for achieving long-term engraftment in gene therapy.
• To determine if specific myelosuppression alone is sufficient for engraftment or if microenvironmental modulation is required.

Main Methods:

• Testing of RIC regimens, including anti-c-Kit antibody with low-dose irradiation and busulfan-based conditioning.
• Utilizing gene-modified autologous transplants expressing green fluorescent protein.
• Monitoring myelosuppression levels and long-term engraftment in nonhuman primates.

Main Results:

• Transient myelosuppression induced by anti-c-Kit antibody and low-dose irradiation resulted in low-level, long-term engraftment.
• Busulfan conditioning, with or without anti-c-Kit, failed to achieve long-term engraftment despite similar myelosuppression.
• Animals in the busulfan groups exhibited characteristics similar to models without immunosuppression, even with treatment.

Conclusions:

• Targeted myelosuppression, such as with anti-c-Kit antibody and low-dose irradiation, may support limited long-term engraftment.
• Current RIC protocols may be insufficient for robust engraftment in nonhematologic conditions.
• Further research is needed to explore combinations of myelosuppression and microenvironmental modulation for effective and safe engraftment.